Alpa Laboratories Limited (BOM:532878)
India · Delayed Price · Currency is INR 69.06
+0.56 (0.82%)
At close: Feb 13, 2026
Alpa Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 1,143 | 1,125 | 1,087 | 929.55 | 1,123 | 975.54 |
Revenue Growth (YoY) | 18.93% | 3.42% | 16.98% | -17.20% | 15.08% | 13.48% |
Cost of Revenue | 844.24 | 760.44 | 746.04 | 616.67 | 761.06 | 647.56 |
Gross Profit | 299.09 | 364.08 | 341.35 | 312.89 | 361.61 | 327.99 |
Selling, General & Admin | 156.55 | 149.55 | 156.15 | 125.47 | 122.82 | 120.04 |
Other Operating Expenses | 144.07 | 167.5 | 99.08 | 106.51 | 132.16 | 121.61 |
Operating Expenses | 325.15 | 339.08 | 274.77 | 245.27 | 271.55 | 253.94 |
Operating Income | -26.06 | 25.01 | 66.58 | 67.62 | 90.06 | 74.05 |
Interest Expense | -1.48 | -2.32 | -3.59 | -0.83 | -1.07 | -0.26 |
Interest & Investment Income | 24.11 | 24.11 | 25.63 | 12.3 | 15.27 | 7.94 |
Earnings From Equity Investments | - | - | - | -0 | 0.07 | -9.36 |
Currency Exchange Gain (Loss) | 8.57 | 8.57 | 7.39 | 19.56 | 2.61 | 4.47 |
Other Non Operating Income (Expenses) | -46.54 | 3.03 | 20.47 | 27.41 | 0.36 | -0 |
EBT Excluding Unusual Items | -41.41 | 58.39 | 116.48 | 126.06 | 107.3 | 76.82 |
Gain (Loss) on Sale of Investments | 197.78 | 197.78 | 90.34 | 32.97 | 88.32 | 31.05 |
Gain (Loss) on Sale of Assets | 0.5 | 0.5 | - | -0.12 | - | - |
Other Unusual Items | -0.37 | - | - | - | - | - |
Pretax Income | 156.51 | 256.67 | 206.82 | 158.9 | 195.62 | 107.87 |
Income Tax Expense | 40.42 | 61.64 | 39.06 | 33.08 | 54.7 | 35.39 |
Net Income | 116.09 | 195.03 | 167.77 | 125.83 | 140.92 | 72.47 |
Net Income to Common | 116.09 | 195.03 | 167.77 | 125.83 | 140.92 | 72.47 |
Net Income Growth | -53.92% | 16.25% | 33.33% | -10.71% | 94.45% | 291.02% |
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 | 21 |
Shares Change (YoY) | -0.23% | - | - | - | -0.00% | 0.00% |
EPS (Basic) | 5.52 | 9.27 | 7.97 | 5.98 | 6.70 | 3.44 |
EPS (Diluted) | 5.52 | 9.27 | 7.97 | 5.98 | 6.70 | 3.44 |
EPS Growth | -53.82% | 16.25% | 33.33% | -10.71% | 94.45% | 291.01% |
Free Cash Flow | - | 69.39 | -27.37 | 77.78 | 77.49 | -49.2 |
Free Cash Flow Per Share | - | 3.30 | -1.30 | 3.70 | 3.68 | -2.34 |
Gross Margin | 26.16% | 32.38% | 31.39% | 33.66% | 32.21% | 33.62% |
Operating Margin | -2.28% | 2.22% | 6.12% | 7.27% | 8.02% | 7.59% |
Profit Margin | 10.15% | 17.34% | 15.43% | 13.54% | 12.55% | 7.43% |
Free Cash Flow Margin | - | 6.17% | -2.52% | 8.37% | 6.90% | -5.04% |
EBITDA | -2.18 | 47.03 | 86.13 | 80.91 | 106.63 | 86.35 |
EBITDA Margin | -0.19% | 4.18% | 7.92% | 8.70% | 9.50% | 8.85% |
D&A For EBITDA | 23.88 | 22.02 | 19.55 | 13.29 | 16.57 | 12.3 |
EBIT | -26.06 | 25.01 | 66.58 | 67.62 | 90.06 | 74.05 |
EBIT Margin | -2.28% | 2.22% | 6.12% | 7.27% | 8.02% | 7.59% |
Effective Tax Rate | 25.82% | 24.02% | 18.88% | 20.82% | 27.96% | 32.81% |
Revenue as Reported | 1,327 | 1,358 | 1,236 | 1,023 | 1,230 | 1,020 |
Advertising Expenses | - | 4.88 | 22.53 | 3.11 | 2.77 | 1.99 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.